FDA-unapproved research compounds

Diabetes Research Stack – EliteBiogenix

1 Retatrutide 10mg 1 BPC-157 5mg 1 CJC1295 DAC 5mg 1 Ipamorelin 5mg

For Controlled Type 2 Diabetes & Metabolic Syndrome Studies – Research Use Only

Diabetes Research Stack – Comprehensive Multi-Target Metabolic Research Solution This advanced, research-grade stack combines four mechanistically distinct compounds for investigating insulin resistance, pancreatic β-cell function, tissue repair, and growth hormone modulation in controlled laboratory settings. Ideal for:

 GLP-1/GIP/glucagon receptor signaling studies  Pancreatic islet cell preservation research  Hepatic & muscle insulin sensitivity assays  Comparative efficacy of metabolic interventions

Diabetes Research Stack – Key Components:

• Retatrutide (LY3437943): Triple agonist (GLP-1/GIP/Glucagon) for glucose homeostasis studies

• BPC-157: Tissue repair peptide for metabolic injury models

• CJC-1295 DAC: Sustained IGF-1 elevation for long-term metabolic tracking

• Ipamorelin: Selective ghrelin agonist for pulsatile GH research

Quality Assurance: ≥98% HPLC-verified purity | Batch-specific CoA | Sterile lyophilization | Endotoxin-tested (<0.1 EU/mg)

 Disclaimer: Strictly for in vitro/ex vivo research by qualified professionals. Not for human/veterinary use. Purchaser assumes full compliance responsibility.

Order Options: Starter (5mg each) | Intermediate (25mg) | Bulk (100mg-1g)

Advance your diabetes research with precision-formulated compounds.